[1]
“ASSESSMENT OF PTEN TUMOR SUPPRESSOR PROTEIN BY IMMUNOHISTOCHEMISTRY IN ENDOMETRIAL HYPERPLASIAS VERSUS CARCINOMAS OVER A FOUR-YEAR PERIOD”, A-JMRHS, vol. 4, no. 2, pp. 1212–1216, Jun. 2026, Accessed: Jul. 01, 2026. [Online]. Available: https://ajmrhs.com/journal/article/view/581